US 11,771,102 B2
Probiotic compositions and methods
Andrea Budelli, Gallarate (IT); Francesca Romana Fasano, Sondrio (IT); Miryam Terzano, Milan (IT); and Lorenzo Bramati, Monza (IT)
Assigned to H.J. Heinz Company Brands LLC, Pittsburgh, PA (US)
Filed by H.J. Heinz Company Brands LLC, Pittsburgh, PA (US)
Filed on Apr. 6, 2021, as Appl. No. 17/223,456.
Application 17/223,456 is a division of application No. 16/360,154, filed on Mar. 21, 2019, granted, now 11,109,603.
Application 15/393,904 is a division of application No. 14/127,573, granted, now 10,039,296, issued on Aug. 7, 2018, previously published as PCT/US2012/042959, filed on Jun. 18, 2012.
Application 16/360,154 is a continuation of application No. 15/393,904, filed on Dec. 29, 2016, granted, now 10,251,407, issued on Apr. 9, 2019.
Claims priority of provisional application 61/498,910, filed on Jun. 20, 2011.
Prior Publication US 2021/0259264 A1, Aug. 26, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A23C 9/123 (2006.01); A23L 7/104 (2016.01); A23L 7/10 (2016.01); A23L 19/00 (2016.01); A23L 33/135 (2016.01); A61K 35/747 (2015.01); A23C 9/127 (2006.01); A23L 33/00 (2016.01); A61K 35/00 (2006.01)
CPC A23C 9/1234 (2013.01) [A23C 9/127 (2013.01); A23L 7/10 (2016.08); A23L 7/104 (2016.08); A23L 19/00 (2016.08); A23L 33/135 (2016.08); A23L 33/40 (2016.08); A61K 35/747 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/63 (2013.01); A61K 2035/115 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A method of treating a subject having a gastrointestinal disorder, the method comprising:
a) identifying a subject having a gastrointestinal disorder;
b) administering to the subject an effective amount of a pharmaceutical composition comprising probiotic bacterium, Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778, wherein the Lactobacillus paracasei CBA L74 cells present in the composition are dead or have been rendered incapable of cell division.